BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 23734707)

  • 21. ΔNp53 and aging.
    Lin SC; Taatjes DJ
    Aging (Albany NY); 2013 Oct; 5(10):717-8. PubMed ID: 24145197
    [No Abstract]   [Full Text] [Related]  

  • 22. Wild-type p53 in cancer cells: when a guardian turns into a blackguard.
    Kim E; Giese A; Deppert W
    Biochem Pharmacol; 2009 Jan; 77(1):11-20. PubMed ID: 18812169
    [TBL] [Abstract][Full Text] [Related]  

  • 23. p53 potentiation of tumor cell susceptibility to CTL involves Fas and mitochondrial pathways.
    Thiery J; Abouzahr S; Dorothee G; Jalil A; Richon C; Vergnon I; Mami-Chouaib F; Chouaib S
    J Immunol; 2005 Jan; 174(2):871-8. PubMed ID: 15634909
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Artificial regulation of p53 function by modulating its assembly.
    Inobe T; Nozaki M; Nukina N
    Biochem Biophys Res Commun; 2015 Nov; 467(2):322-7. PubMed ID: 26454170
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Activation of the PI3K-AKT-mTOR signaling pathway promotes DEHP-induced Hep3B cell proliferation.
    Chen X; Qin Q; Zhang W; Zhang Y; Zheng H; Liu C; Yang Y; Xiong W; Yuan J
    Food Chem Toxicol; 2013 Sep; 59():325-33. PubMed ID: 23793038
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Negative regulation of beta4 integrin transcription by homeodomain-interacting protein kinase 2 and p53 impairs tumor progression.
    Bon G; Di Carlo SE; Folgiero V; Avetrani P; Lazzari C; D'Orazi G; Brizzi MF; Sacchi A; Soddu S; Blandino G; Mottolese M; Falcioni R
    Cancer Res; 2009 Jul; 69(14):5978-86. PubMed ID: 19567674
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of STAT3/p53 and PI3K-Akt-mTOR signaling pathway on DEHP-induced reproductive toxicity in pubertal male rat.
    Fu G; Dai J; Li Z; Chen F; Liu L; Yi L; Teng Z; Quan C; Zhang L; Zhou T; Donkersley P; Song S; Shi Y
    Toxicol Appl Pharmacol; 2020 Oct; 404():115151. PubMed ID: 32710958
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cellular localization of human p53 expressed in the yeast Saccharomyces cerevisiae: effect of NLSI deletion.
    Abdelmoula-Souissi S; Delahodde A; Bolotin-Fukuhara M; Gargouri A; Mokdad-Gargouri R
    Apoptosis; 2011 Jul; 16(7):746-56. PubMed ID: 21553245
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of Long Form of CAPON Overexpression on Glioma Cell Proliferation are Dependent on AKT/mTOR/P53 Signaling.
    Liang D; Song Y; Fan G; Ji D; Zhang T; Nie E; Liu X; Liang J; Yu R; Gao S
    Int J Med Sci; 2019; 16(4):614-622. PubMed ID: 31171914
    [No Abstract]   [Full Text] [Related]  

  • 30. Cellular and organismal ageing: Role of the p53 tumor suppressor protein in the induction of transient and terminal senescence.
    Schmid G; Kramer MP; Maurer M; Wandl S; Wesierska-Gadek J
    J Cell Biochem; 2007 Aug; 101(6):1355-69. PubMed ID: 17471501
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The combination of Nutlin-3 and Tanshinone IIA promotes synergistic cytotoxicity in acute leukemic cells expressing wild-type p53 by co-regulating MDM2-P53 and the AKT/mTOR pathway.
    Guo Y; Li Y; Wang FF; Xiang B; Huang XO; Ma HB; Gong YP
    Int J Biochem Cell Biol; 2019 Jan; 106():8-20. PubMed ID: 30389549
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Wild-Type p53 Promotes Cancer Metabolic Switch by Inducing PUMA-Dependent Suppression of Oxidative Phosphorylation.
    Kim J; Yu L; Chen W; Xu Y; Wu M; Todorova D; Tang Q; Feng B; Jiang L; He J; Chen G; Fu X; Xu Y
    Cancer Cell; 2019 Feb; 35(2):191-203.e8. PubMed ID: 30712844
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oridonin-induced mitochondria-dependent apoptosis in esophageal cancer cells by inhibiting PI3K/AKT/mTOR and Ras/Raf pathways.
    Jiang JH; Pi J; Jin H; Cai JY
    J Cell Biochem; 2019 Mar; 120(3):3736-3746. PubMed ID: 30229997
    [TBL] [Abstract][Full Text] [Related]  

  • 34. mTOR inactivation in myocardium from infant mice rapidly leads to dilated cardiomyopathy due to translation defects and p53/JNK-mediated apoptosis.
    Mazelin L; Panthu B; Nicot AS; Belotti E; Tintignac L; Teixeira G; Zhang Q; Risson V; Baas D; Delaune E; Derumeaux G; Taillandier D; Ohlmann T; Ovize M; Gangloff YG; Schaeffer L
    J Mol Cell Cardiol; 2016 Aug; 97():213-25. PubMed ID: 27133769
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthetic mRNA nanoparticle-mediated restoration of p53 tumor suppressor sensitizes
    Kong N; Tao W; Ling X; Wang J; Xiao Y; Shi S; Ji X; Shajii A; Gan ST; Kim NY; Duda DG; Xie T; Farokhzad OC; Shi J
    Sci Transl Med; 2019 Dec; 11(523):. PubMed ID: 31852795
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mutant p53 and mTOR/PKM2 regulation in cancer cells.
    Dando I; Cordani M; Donadelli M
    IUBMB Life; 2016 Sep; 68(9):722-6. PubMed ID: 27385486
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mechanism of miR-122-5p regulating the activation of PI3K-Akt-mTOR signaling pathway on the cell proliferation and apoptosis of osteosarcoma cells through targeting TP53 gene.
    Li KW; Wang SH; Wei X; Hou YZ; Li ZH
    Eur Rev Med Pharmacol Sci; 2020 Dec; 24(24):12655-12666. PubMed ID: 33378012
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sensitization of cis-platinum by a recombinant adenovirus vector expressing wild-type p53 gene in human ovarian carcinomas.
    Song K; Li Z; Seth P; Cowan KH; Sinha BK
    Oncol Res; 1997; 9(11-12):603-9. PubMed ID: 9563008
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of Δ40p53, an isoform of p53 lacking the N-terminus, on transactivation capacity of the tumor suppressor protein p53.
    Hafsi H; Santos-Silva D; Courtois-Cox S; Hainaut P
    BMC Cancer; 2013 Mar; 13():134. PubMed ID: 23514281
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cdk2 kinase phosphorylates serine 315 of human p53 in vitro.
    Price BD; Hughes-Davies L; Park SJ
    Oncogene; 1995 Jul; 11(1):73-80. PubMed ID: 7624134
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.